News Merck’s net income for Q1 2024 increases by 69% to $4.76bn The company’s sales for Q1 2024 increased by 9% to $15.77bn.
Data Insights Q4 2023 update: remote patient monitoring related M&A activity in the pharmaceutical industry
Data Insights Q4 2023 update: electronic medical record (emr) systems related M&A activity in the pharmaceutical industry
Data Insights Q4 2023 update: environmental sustainability related M&A activity in the pharmaceutical industry
News Signal: Novo Nordisk sues more Florida pharmacies in battle against fake semaglutide Isaac Hanson